EDGE MEDICAL-B 02675·

Gross margin --------59.25%--61.30%2.05%65.97%4.67% Net margin ---------443.09%---136.57%306.52%-19.44%117.13% ROE 89.88%---18.74%108.62%-14.80%---17.34%2.54%-7.39%9.95% ROA -50.69%---18.28%32.41%-13.68%---16.06%2.37%-6.39%9.66% Revenue growth ------------233.03%--184.83%48.20% Attributable profit growth -----340.08%-------2.65%--59.45%62.10% Debt-to-assets 156.40%--2.43%153.97%7.54%--7.41%0.13%13.50%6.09% Current ratio 0.58--53.0152.4317.41--14.572.858.116.45 Operating cash flow / net profit 0.49--0.320.171.50--1.030.482.191.16 Operating cash flow / revenue ---------666.72%---140.41%526.31%-42.63%97.77%

Gross margin 62.83%--64.08%1.26% Net margin -59.64%---6.03%53.61% Revenue growth ----113.76%-- Attributable profit growth ----78.39%-- Debt-to-assets ----2.20%-- Current ratio ----19.49--

Revenue --------48.04M--159.99M233.03%455.71M184.83% Other income and gains 728.00K--32.00K95.60%------------ Gross profit --------28.47M--98.08M244.54%300.65M206.55% Selling and distribution expenses ----3.80M--62.28M--101.21M62.49%134.81M33.21% Administrative expenses 7.83M--52.11M565.86%61.85M--52.63M14.90%90.51M71.96% Net finance costs 14.38M--73.25M409.35%985.00K--863.00K12.39%541.00K37.31% Operating profit -64.98M---276.02M324.75%-211.88M---217.65M2.72%-88.07M59.54% Profit before tax -79.37M---349.27M340.08%-212.87M---218.51M2.65%-88.61M59.45% Net profit -79.37M---349.27M340.08%-212.87M---218.51M2.65%-88.61M59.45% Net profit attributable to owners -79.37M---349.27M340.08%-212.87M---218.51M2.65%-88.61M59.45%

Revenue 149.38M--319.32M113.76% Other income and gains 6.44M---28.33M539.75% Cost of sales 55.53M--114.69M106.52% Gross profit 93.85M--204.63M118.04% Selling and distribution expenses 58.73M--87.46M48.93% Administrative expenses 39.35M--26.50M32.67% Net finance costs 310.00K--618.00K99.35% Income tax 22.00K--0100.00% Operating profit -88.75M---18.64M79.00% Share of associates and JVs -68.00K---10.00K85.29% Profit before tax -89.06M---19.25M78.38% Net profit -89.09M---19.25M78.39% Net profit attributable to owners -89.09M---19.25M78.39%

Cash and cash equivalents 37.21M--1.51B3946.59%155.31M--119.81M22.86%86.04M28.19% Trade and bills receivables 143.00K------18.54M--48.10M159.49%213.45M343.73% Inventories --------77.16M--73.71M4.48%136.11M84.66% Total current assets 137.17M--1.87B1266.90%1.35B--1.26B6.34%1.33B5.50% Total assets 156.56M--1.91B1120.10%1.56B--1.36B12.53%1.39B1.84% Total current liabilities 235.85M--35.37M85.00%77.55M--86.83M11.98%164.44M89.38% Total liabilities 244.87M--46.39M81.05%117.30M--100.77M14.09%187.03M85.59% Equity attributable to owners -88.30M--1.86B2210.70%1.44B--1.26B12.40%1.20B4.86% Total equity -88.30M--1.86B2210.70%1.44B--1.26B12.40%1.20B4.86%

Cash and cash equivalents ----1.26B-- Trade and bills receivables ----255.41M-- Inventories ----158.14M-- Total current assets ----2.36B-- Total assets ----2.36B-- Total current liabilities ----120.98M-- Total liabilities ----51.80M-- Equity attributable to owners ----2.31B-- Total equity ----2.31B--

Net cash from operating activities -38.87M---111.93M187.94%-320.31M---224.64M29.87%-194.29M13.51% Net cash from investing activities -72.06M---263.27M265.36%383.73M--196.25M48.86%170.45M13.15% Net cash from financing activities 145.48M--1.85B1168.23%-9.18M---7.34M20.05%-9.33M27.03% Net change in cash 34.55M--1.47B4154.45%54.24M---35.73M165.88%-33.17M7.18%